Business
Abattis annouces grant of stock option
Abattis annouces grant of stock option.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"\n\nv\\:* {behavior:url(#default#VML);}\no\\:* {behavior:url(#default#VML);}\nw\\:* {behavior:url(#default#VML);}\n.shape {behavior:url(#default#VML);}\n\n\n\nABATTIS ANNOUNCES\nGRANT OF OPTION\n\n \n\n \n\nVancouver,\nBC ? February 27, 2014 - Abattis Bioceuticals Corp. (the\n?Company? or ?Abattis?) (OTC PINK: ATTBF) (CSE: ATT) wishes to announce that it\nhas granted incentive stock options to a consultant of the Company to purchase\nup to 110,000 common shares of the Company. \nThe options are exercisable on or before February 27, 2019, at an\nexercise price of $0.36 per share.\n\n \n\nAbout Abattis Bioceuticals Corp.\n\nAbattis is a\nspecialty biotechnology company with capabilities through its wholly owned\nsubsidiaries of cultivating, licensing and marketing proprietary ingredients,\nbio-similar compounds, patented equipment and consulting services to medicinal\nmarkets in North America. The company is positioned to capitalize on the fast\ngrowing trend toward marijuana legalization in the United States and for\nmedicinal use in Canada and international jurisdictions by supplying and\npartnering with companies to employ its vertical cultivation systems,\nextraction equipment/technology, and strategic marketing support to licensed\ngrowers. The company also has an extensive pipeline of high-quality products\nand Intellectual Property for the rapidly expanding botanical drug market. We\nfollow strict Standard Operating Protocols and adhere to the Law's of Canada\nand Foreign Jurisdictions. For more information, visit the Company?s\nwebsite at www.abattis.com.\n\n \n\nFor further information, contact the Company?s CEO,\nMichael Withrow at (778) 896-6536 or at [email protected].\n\n \n\nON BEHALF OF\nTHE BOARD\n\n \n\n?Michael Withrow?\n\nPresident\n& CEO\n\n \n\n \n\nNEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS\nREGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE\nADEQUACY OR ACCURACY OF THIS RELEASE.\n\n \n\nFORWARD LOOKING INFORMATION\n\nThis press\nrelease contains forward-looking statements. The use of any of the words\n\"anticipate\", \"continue\", \"estimate\", \"expect\",\n\"may\", \"will\", \"project\", \"should\",\n\"believe\" and similar expressions are intended to identify\nforward-looking statements. Although the\nCompany...